Related Experiment Video
Updated: Feb 5, 2026

In vitro Cell Migration and Invasion Assays
Published on: June 1, 2014
MicroRNA-1301 inhibits migration and invasion of osteosarcoma cells by targeting BCL9
Lei Wang1, Kejun Hu1, Yu Chao1
1Department of Orthopaedics, The First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi 710077, China.
Abstract:
Increasing reports demonstrated that miRNAs play a critical role in tumor development and progression. Previous studies revealed that miR-1301 was abnormally expressed in various cancers. However, its function and underlying mechanism in osteosarcoma (OS) remains unknown. In this study, miR-1301 expression was significantly down-regulated in both OS tissues and cell lines. Down-regulated miR-1301 was obviously associated with malignant clinical features and poor overall survival of OS patients. miR-1301 overexpression inhibited cell proliferation, migration and invasion. In addition, we identified BCL9 act as a direct target of miR-1301 by directly binding to its 3'-UTR. In clinical OS tissues, miR-1301 negatively correlated BCL9 expression. BCL9 was up-regulated in OS tissues and cells. BCL9 overexpression promoted OS progression. Moreover, restoration of BCL9 expression at least partially abolished the proliferation, migration and invasion of miR-1301 on OS cells. In conclusion, our data indicated that miR-1301 inhibited cell proliferation, migration and invasion of OS by targeting BCL9, and may represent a novel potential therapeutic target and prognostic marker for OS.
Insights
MicroRNA-1301 (miR-1301) is down-regulated in osteosarcoma (OS) and inhibits tumor progression by targeting BCL9. Lower miR-1301 levels correlate with poor patient survival, suggesting its potential as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MicroRNAs (miRNAs) are crucial regulators in cancer development.
- Previous research indicates abnormal miR-1301 expression in several cancers, but its role in osteosarcoma (OS) is unclear.
Purpose of the Study:
- To investigate the function and mechanism of miR-1301 in osteosarcoma.
- To determine if miR-1301 can serve as a prognostic marker for OS patients.
Main Methods:
- Compared miR-1301 expression in OS tissues and cell lines versus normal controls.
- Overexpressed miR-1301 in OS cells to assess effects on proliferation, migration, and invasion.
- Identified and validated BCL9 as a direct target of miR-1301 using 3'-UTR binding assays.
- Correlated miR-1301 and BCL9 expression in clinical OS samples.
Main Results:
- miR-1301 expression was significantly lower in OS tissues and cell lines.
- Down-regulated miR-1301 correlated with advanced clinical features and reduced patient survival.
- Overexpression of miR-1301 suppressed OS cell proliferation, migration, and invasion.
- BCL9 was identified as a direct target of miR-1301, with inverse expression correlation in OS.
- BCL9 overexpression promoted OS progression, and its restoration partially reversed miR-1301's inhibitory effects.
Conclusions:
- miR-1301 inhibits osteosarcoma cell proliferation, migration, and invasion by targeting BCL9.
- miR-1301 functions as a tumor suppressor in OS.
- miR-1301 holds potential as a novel therapeutic target and prognostic biomarker for osteosarcoma.
Related Concept Videos
MicroRNAs
MicroRNAs
Cell Migration
Cell Migration
Feedback Inhibition
Cancer Cell Migration through Invadopodia

